DAFNA Capital Management as of June 30, 2012
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 57 positions in its portfolio as reported in the June 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pharmacyclics | 12.3 | $9.0M | 166k | 54.61 | |
| Novadaq Technologies | 9.3 | $6.8M | 1.0M | 6.80 | |
| Ariad Pharmaceuticals | 7.5 | $5.5M | 320k | 17.21 | |
| Threshold Pharmaceuticals | 5.8 | $4.2M | 571k | 7.40 | |
| Ym Biosciences | 5.7 | $4.2M | 2.1M | 1.99 | |
| Insulet Corporation (PODD) | 4.8 | $3.5M | 165k | 21.37 | |
| Insulet Corporation Cvt 3.75 0 convert | 4.5 | $3.3M | 3.0M | 1.11 | |
| Dynavax Technologies Corporation | 4.2 | $3.1M | 714k | 4.32 | |
| Discovery Laboratories | 3.2 | $2.4M | 1.0M | 2.32 | |
| Rigel Pharmaceuticals (RIGL) | 3.1 | $2.3M | 248k | 9.30 | |
| Protalix BioTherapeutics | 3.0 | $2.2M | 386k | 5.73 | |
| ISIS Pharmaceuticals | 2.3 | $1.7M | 141k | 12.00 | |
| Given Imaging | 1.9 | $1.4M | 87k | 15.80 | |
| TranS1 (TSON) | 1.7 | $1.2M | 497k | 2.48 | |
| Cardica | 1.6 | $1.2M | 635k | 1.88 | |
| XenoPort | 1.6 | $1.2M | 193k | 6.04 | |
| Theragenics Corporation | 1.5 | $1.1M | 555k | 2.01 | |
| InfuSystem Holdings (INFU) | 1.4 | $1.0M | 542k | 1.89 | |
| Mannkind Corp note 3.750%12/1 | 1.4 | $1.0M | 1.9M | 0.53 | |
| Nuvasive Inc. conv | 1.3 | $980k | 1.0M | 0.98 | |
| Cardionet | 1.3 | $951k | 468k | 2.03 | |
| AtriCure (ATRC) | 1.3 | $943k | 98k | 9.61 | |
| BioSpecifics Technologies | 1.2 | $907k | 48k | 18.78 | |
| RTI Biologics | 1.2 | $877k | 233k | 3.76 | |
| Derma Sciences | 1.2 | $875k | 92k | 9.52 | |
| Spectranetics Corporation | 1.2 | $849k | 74k | 11.42 | |
| Cutera (CUTR) | 1.1 | $828k | 115k | 7.20 | |
| Greatbatch | 1.0 | $759k | 33k | 22.70 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.9 | $688k | 12k | 55.93 | |
| Johnson & Johnson (JNJ) | 0.9 | $635k | 9.4k | 67.55 | |
| Viking Systems | 0.8 | $592k | 3.5M | 0.17 | |
| Exactech | 0.8 | $564k | 34k | 16.77 | |
| Gilead Sciences (GILD) | 0.7 | $546k | 11k | 51.27 | |
| Dex (DXCM) | 0.7 | $525k | 41k | 12.96 | |
| Achillion Pharmaceuticals | 0.7 | $520k | 84k | 6.21 | |
| Dendreon Corporation | 0.7 | $511k | 69k | 7.40 | |
| Masimo Corporation (MASI) | 0.5 | $392k | 18k | 22.40 | |
| Conceptus | 0.5 | $382k | 19k | 19.82 | |
| Vascular Solutions | 0.5 | $364k | 29k | 12.55 | |
| Edap Tms (EDAP) | 0.5 | $360k | 185k | 1.94 | |
| Cytokinetics | 0.5 | $347k | 542k | 0.64 | |
| Digirad Corporation | 0.5 | $330k | 149k | 2.21 | |
| Cardiovascular Systems | 0.4 | $279k | 29k | 9.80 | |
| Transgenomic | 0.4 | $271k | 301k | 0.90 | |
| Graymark Healthcare | 0.4 | $266k | 700k | 0.38 | |
| Trovagene | 0.3 | $244k | 63k | 3.90 | |
| Trius Therapeutics | 0.3 | $191k | 33k | 5.75 | |
| Neuralstem | 0.2 | $181k | 197k | 0.92 | |
| Stereotaxis | 0.2 | $169k | 804k | 0.21 | |
| Misonix | 0.2 | $150k | 64k | 2.33 | |
| Unilife US | 0.2 | $135k | 40k | 3.38 | |
| Neurometrix | 0.2 | $123k | 199k | 0.62 | |
| Biolinerx Ltd-spons | 0.1 | $113k | 47k | 2.43 | |
| Sunshine Heart | 0.1 | $95k | 29k | 3.25 | |
| Trovagene Inc *w Exp 99/99/999 | 0.0 | $22k | 31k | 0.70 | |
| Medlink International | 0.0 | $6.3k | 157k | 0.04 | |
| Combimatrix Corporation *w exp 05/01/201 | 0.0 | $2.1k | 23k | 0.09 |
